Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT06357845
Other study ID # CASE5Z24
Secondary ID 1R21ES036031-01
Status Not yet recruiting
Phase N/A
First received
Last updated
Start date July 1, 2024
Est. completion date January 31, 2026

Study information

Verified date June 2024
Source Case Comprehensive Cancer Center
Contact Fredrick R Schumacher, PhD
Phone 216-368-0351
Email healthyfutures@case.edu
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The goal of this study is to This research team is conducting this study to develop methods to measure the biological impact of exposure to the chemicals released following the February 3, 2023 train derailment on residents of East Palestine, Ohio, and surrounding communities. The main question it aims to answer is: - What biological impact will be measured based on DNA damage? - In participants who provide a biospecimen, how are biomarker changes related to proximity to the derailment and variations in residents' health histories and behaviors? Participants will: - Complete a brief survey asking about experiences related to the February 3, 2023 train derailment, health experiences, and concerns following the derailment, and background information regarding health history. - Possibly contribute biospecimens such as blood, spit, hair, and/or toenail clippings. - Receive communication about study updates and future research opportunities. - A total of 40 study participants will be recruited to participate in a 90-minute interview. The interviews will be video and audio recorded.


Description:

On February 3, 2023, at 8:55 pm EST, over 30 train cars from a Norfolk Southern train carrying hazardous chemicals derailed in the village of East Palestine, Ohio. In a few hours, residents within a 1- mile radius were ordered to evacuate, followed by several shelter-in-place orders. By February 6, the evacuation zone was expanded, and a controlled burn was implemented in the hopes of preventing an explosion. A week later, the Environmental Protection Agency (EPA) announced vinyl chloride, butyl acrylate, ethylhexyl acrylate, and ethylene glycol monobutyl ether were released into the air, surface soil, and surface waters. Although the EPA failed to detect contaminants at concerning levels for human health in the East Palestine region on February 12, East Palestine residents with private wells were recommended to use bottled water only four days later, and subsequent testing has detected elevated chemical levels in the region. The EPA instructed Norfolk Southern to expand testing and include dioxin testing on March 2. Four days later seven members of a 15-person CDC/ATSDR team reported sore throats, headaches, coughing and nausea after conducting Assessment of Chemical Exposure (ACE) surveys. The inconsistent messaging from the EPA and other governmental agencies have frustrated East Palestine and surrounding community (EPSC) residents, and generated concerns regarding long-term health effects. This study has several aims: - Establish the Healthy Futures Pilot Cohort utilizing a community-engaged research approach - Compare genotoxicity levels arising from chemical exposure by geographical proximity and direction from the train derailment epicenter utilizing the somatic mutation rate in DNA among residents - Understand experiences during and post-disaster with respect to effects on quality of life, perceived stressors, future prospects, and overall health-and how acute disasters shape risk perception, coping strategies, and access to health-protective resources through semi-structured interviews.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 500
Est. completion date January 31, 2026
Est. primary completion date September 1, 2025
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Residence on February 3rd, 2023 in Columbiana County, Ohio, Mahoning County, Ohio, Beaver County, PA, or Lawrence County, PA. - Current residence in the United States. Exclusion Criteria: - Address provided for February 3rd, 2023 not in Columbiana County, Ohio, Mahoning County, Ohio, Beaver County, PA, or Lawrence County, PA - Invalid address provided for February 3rd, 2023 residence.

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Survey
Participants will complete a brief web-based survey asking about their experiences related to the February 3, 2023 train derailment, health experiences and concerns following the derailment, and background information regarding their health history. The survey will last approximately 15 minutes.
Biological specimen collection
Participants may possibly contribute biospecimens such as blood, spit, hair, and/or toenail clippings. Participants will be asked which samples they are interested in providing. Participants will receive a specific sample collection kit based on their selection. For blood samples, participants will receive a mailed collection kit at their mailing address. A member of the research team will reach out to schedule blood sample collection, which may take place at home with a trained phlebotomist or at a designated collection site. A total of 1-2 teaspoons of blood (5-10 milliliters) will be collected at a one-time blood draw. For either saliva, hair, and/or toenail clippings, participants will be sent a sample collection kit and receive instructions at their mailing address. This kit also includes a return mailing envelope. Participants will provide the selected samples in the collection kits, place them in the return mailing envelope, and send them back to the research team.
Communications about study updates and future research opportunities
By consenting to participate in this study, the research team will send updates about the research results and any additional study opportunities to participants.
Qualitative interview
A total of 40 study participants will be recruited to participate in a 90-minute interview with open-ended questions. The interviews will be video and audio-recorded.

Locations

Country Name City State
n/a

Sponsors (3)

Lead Sponsor Collaborator
Case Comprehensive Cancer Center National Institute of Environmental Health Sciences (NIEHS), National Institutes of Health (NIH)

Outcome

Type Measure Description Time frame Safety issue
Primary Geographic Association of Somatic Mutation Rates The primary outcome measure is somatic mutation rates in association with geographical distance from the train derailment epicenter. Up to 24 months
Secondary Self-reported Symptomology Association of Somatic Mutation Rates The secondary outcome measure is somatic mutation rates in association with self-reported symptomology at time of exposure. Up to 24 months
See also
  Status Clinical Trial Phase
Recruiting NCT01994057 - A Retrospective Study of EGFR-TKIs,Gefitinib, Erlotinib and Osimertinib in NSCLC Patients Treatment
Not yet recruiting NCT04788927 - Development of a Predictive Model for the Risk of Metastatic Disease in PPGLs, a Retrospective Cohort Study
Recruiting NCT05364294 - Molecular Diagnosis of Systemic Autoinflammatory Diseases
Recruiting NCT05735717 - MT2021-08T Cell Receptor Alpha/Beta Depletion PBSC Transplantation for Heme Malignancies Phase 2
Recruiting NCT06054295 - Somatic Mosaicism in Twins Discordant for Childhood Cancer
Recruiting NCT03092128 - A Retrospective Pharmacokinetics and Pharmacogenomics Research of Imatinib in Gastrointestinal Stromal Tumor Treatment
Recruiting NCT04516083 - Lynch Syndrome Can be Diagnosed Just From Somatic Mismatch Repair Mutation